Skip to content
No picture yet

Colestid Tablets 1 g – DIN 02132680

Colestid Tablets is Colestipol Hydrochloride 1 g (tablet), sold in Canada. It is used for high cholesterol, high triglycerides and heart disease. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Colestipol Hydrochloride 1 g

Brand
Colestid Tablets
Strength
1 g
Used for
High cholesterol, high triglycerides and heart disease
Form
Tablet
Manufacturer
Pfizer Canada ULC
Drug class
Bile acid sequestrant
Sold in
Canada
DIN
02132680

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Colestipol Hydrochloride pills and guides

What is Colestipol Hydrochloride used for?

Colestipol Hydrochloride is used for high cholesterol, high triglycerides, heart disease and diarrhea.

Medicine type
Bile acid sequestrant
Official uses from the US prescribing label

Since no drug is innocuous, strict attention should be paid to the indications and contraindications, particularly when selecting drugs for chronic long-term use.

Colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with primary hypercholesterolemia (elevated LDL-C) who do not respond adequately to diet. Generally, colestipol hydrochloride tablets have no clinically significant effect on serum triglycerides, but with their use, triglyceride levels may be raised in some patients.

Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Treatment should begin and continue with dietary therapy (see NCEP guidelines). A minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy. Shorter periods may be considered in patients with severe elevations of LDL-C or with definite CHD.

According to the NCEP guidelines, the goal of treatment is to lower LDL-C, and LDL-C is to be used to initiate and assess treatment response. Only if LDL-C levels are not available, should the Total-C be used to monitor therapy. The NCEP treatment guidelines are shown below.

*Coronary heart disease or peripheral vascular disease (including symptomatic carotid artery disease). †Other risk factors for coronary heart disease (CHD) include: age (males: ≥45 years; female: ≥55 years or premature menopause without estrogen replacement therapy); family history of premature CHD; current cigarette smoking; hypertension; confirmed HDL-C <35 mg/dL (0.91 mmol/L); and diabetes mellitus. Subtract one risk factor if HDL-C is ≥60 mg/dL (1.6 mmol/L).

From the FDA-approved label on DailyMed (published Sep 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02132680.
  • It names Colestid Tablets, Colestipol Hydrochloride 1 g.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Colestid Tablets by Pfizer Canada ULC.

In Canada: prescription only.

Ingredients

Active: Colestipol Hydrochloride

Other Colestipol Hydrochloride pills